Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanya Mehta

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisYosuke Sakamachi, Emma Wiley, Alma Solis, et al.
Science Translational Medicine|June 3, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPFYosuke Sakamachi, Emma Wiley, Carol S Trempus, et al.
Nature|March 26, 2026
Dominant clones leverage developmental epigenomic states to drive ependymomaAlisha S Kardian, Hua Sun, Siri Ippagunta, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisYosuke Sakamachi, Emma Wiley, Alma Solis, et al.
Science Translational Medicine|June 3, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPFYosuke Sakamachi, Emma Wiley, Carol S Trempus, et al.
Nature|March 26, 2026
Dominant clones leverage developmental epigenomic states to drive ependymomaAlisha S Kardian, Hua Sun, Siri Ippagunta, et al.
Pageof 2